Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G de Groot

Showing results (241-250 of 275) with videos related to

Pageof 28
Sort By:
Circulation|September 24, 1999
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in womenM Roest, Y T van der Schouw, B de Valk, et al.
Thrombosis and Haemostasis|May 1, 1997
von Willebrand factor without the A2 domain is resistant to proteolysisH Lankhof, C Damas, M E Schiphorst, et al.
British Journal of Haematology|December 1, 1996
Thrombomodulin activity on mesothelial cells: perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular graftsH J Verhagen, G J Heijnen-Snyder, A Pronk, et al.
The Journal of Biological Chemistry|February 25, 1993
Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein CT M Hackeng, M Hessing, C van 't Veer, et al.
Thrombosis and Haemostasis|October 1, 1996
Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosusR Fijnheer, D A Horbach, R C Donders, et al.
Cytogenetics and Cell Genetics|January 1, 1981
Characterization of the Philadelphia chromosome by gene mappingA H Geurts van Kessel, H ten Brinke, W A Boere, et al.
Blood|November 15, 1996
Platelet adhesion to collagen type IV under flow conditionsG Henrita van Zanten, E U Saelman, K M Schut-Hese, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activityI Dienava-Verdoold, M G Boon-Spijker, P G de Groot, et al.
Thrombosis Research|January 15, 1992
In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasmaP A d'Alessio, G Castaman, F Rodeghiero, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2010
von Willebrand factor propeptide and the occurrence of a first ischemic strokeM C van Schie, M P M DE Maat, D W J Dippel, et al.
Pageof 28

Showing results (241-250 of 275) with videos related to

Sort By:
Pageof 28
Circulation|September 24, 1999
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in womenM Roest, Y T van der Schouw, B de Valk, et al.
Thrombosis and Haemostasis|May 1, 1997
von Willebrand factor without the A2 domain is resistant to proteolysisH Lankhof, C Damas, M E Schiphorst, et al.
British Journal of Haematology|December 1, 1996
Thrombomodulin activity on mesothelial cells: perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular graftsH J Verhagen, G J Heijnen-Snyder, A Pronk, et al.
The Journal of Biological Chemistry|February 25, 1993
Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein CT M Hackeng, M Hessing, C van 't Veer, et al.
Thrombosis and Haemostasis|October 1, 1996
Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosusR Fijnheer, D A Horbach, R C Donders, et al.
Cytogenetics and Cell Genetics|January 1, 1981
Characterization of the Philadelphia chromosome by gene mappingA H Geurts van Kessel, H ten Brinke, W A Boere, et al.
Blood|November 15, 1996
Platelet adhesion to collagen type IV under flow conditionsG Henrita van Zanten, E U Saelman, K M Schut-Hese, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activityI Dienava-Verdoold, M G Boon-Spijker, P G de Groot, et al.
Thrombosis Research|January 15, 1992
In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasmaP A d'Alessio, G Castaman, F Rodeghiero, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2010
von Willebrand factor propeptide and the occurrence of a first ischemic strokeM C van Schie, M P M DE Maat, D W J Dippel, et al.
Pageof 28